Xeris Pharmaceuticals XERS 深 沪
已收盘 02-06 16:00:00 美东时间
7.01
+0.100
+1.45%
华盛通- 最 高7.10
- 今 开7.00
- 成交量 98.32万股
- 最 低 6.93
- 昨 收 6.91
- 总市值 11.63亿
- 52周最高 10.08
- 市盈率 静 --
- 换手率 0.59%
- 52周最低 3.5599
- 委 比 95.62%
- 总股本 1.66亿
- 历史最高 27.983
- 量 比 0.67
- 振 幅 2.46%
- 历史最低 0.9701
- 每 手 1
- 风险率 1.69%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 瑞穗上调英伟达、谷歌、美光科技、SanDisk多家科技股目标价；中金首予诺和诺德"跑赢大市"评级，目标价73.5美元
今日重点评级关注：Needham：维持Cartesian Therapeutics"买入"评级，目标价从40美元升至42美元；Piper Sandler：维持Acrivon Therapeutics"超配"评级，目标价从6美元升至8美元
01-12 14:09
Xeris Biopharma Holdings shares are trading higher after the company issued FY25 revenue guidance above estimates.
Xeris Biopharma Holdings shares are trading higher after the company issued FY2...
01-09 02:17
美股大行评级 | 花旗上调苹果目标价升至330美元；GPCR、KYMR、MAMA、TERN、WVE等获多家机构上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从12美元升至13美元；Guggenheim：维持Praxis Precision Medicine"买入"评级，目标价从540美元升至760美元
2025-12-10 10:33
Barclays Initiates Coverage On Xeris Biopharma Holdings with Overweight Rating, Announces Price Target of $9
Barclays analyst Glen Santangelo initiates coverage on Xeris Biopharma Holdings (NASDAQ:XERS) with a Overweight rating and announces Price Target of $9.
2025-12-10 00:28
Xeris Biopharma Holdings shares are trading lower. The company reported Q3 financial results.
Xeris Biopharma Holdings shares are trading lower. The company reported Q3 fina...
2025-11-06 22:27
Xeris Biopharma Holdings Raises FY2025 Sales Guidance from $280.000M-$290.000M to $285.000M-$290.000M vs $286.467M Est
Xeris Biopharma Holdings (NASDAQ:XERS) raises FY2025 sales outlook from $280.000 million-$290.000 million to $285.000 million-$290.000 million vs $286.467 million estimate.
2025-11-06 20:03
American Regent And Xeris Pharmaceuticals Launch Gvoke VialDx, First Concentrated Liquid Glucagon For Diagnostic GI Procedures
First concentrated, ready-to-dilute liquid glucagon available for diagnostic proceduresSHIRLEY, N.Y., Aug. 27, 2025 /PRNewswire/ -- American Regent, Inc.® is pleased to announce the commercial launch and
2025-08-27 20:39
American Regent® Launches Gvoke VialDx™ (glucagon injection)
First concentrated, ready-to-dilute liquid glucagon available for diagnostic procedures SHIRLEY, N.Y., Aug. 27, 2025 /PRNewswire/ -- American Regent, Inc.® is pleased to announce the commerc...
2025-08-27 20:35
Xeris Biopharma Holdings shares are trading higher after the company reported Q2 financial results and beat its EPS and sales estimates. Also, the company raised its FY25 sales guidance above estimates.
Xeris Biopharma Holdings shares are trading higher after the company reported Q...
2025-08-07 20:52
Xeris Biopharma Holdings shares are trading lower. The company released Its strategy for long-term growth and value creation at 2025 analyst & investor day.
Xeris Biopharma Holdings shares are trading lower. The company released Its str...
2025-06-04 00:11
